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The work of Anderson and Frost (1), Peabody, Draper and Dochez 
(2), Leake (3), Aycock and Kramer (4) and others has shown that the 
serum of so called normal individuals, who have had no clinical history 
of poliomyelitis,  may neutralize  the  virus  of poliomyelitis.  Aycock 
and Kramer (4), Schultz and Gebhardt (5), found this specific neutral- 
izing power in the serum of most urban adults. 
On the grounds that the majority of urban adults are thought to be 
immune  to  poliomyelitis,  tests  had  been  made  for the presence of 
neutralizing substances in the sera of twenty-nine adults,  thirteen of 
whom had  a  history of contact with cases of poliomyelitis and all of 
whom denied a  history of clinical symptoms.  At the same time, the 
potency of the serums was compared with that of pooled convalescent 
serums. 
Anderson and Frost (1) were the first to demonstrate neutralizing substance for 
the virus of poliomyelitis in the serums of non-convalescent  adults and Peabody, 
Draper and I)ochez (2), in their studies,  found four out of six serums,  obtained 
from individuals  with no clinical  history of the disease,  neutralized the virus. 
Later Leake (3) made similar  observations,  but the first extensive study in this 
direction was undertaken by Aycock and Kramer (4) who, in their series of urban 
residents,  found 69.6 per cent with neutralizing substance and that the serums of 
87.5 per cent of the adults of this group neutralized the virus.  Likewise, Schultz 
and Gebhardt (5) showed that, of thirteen so called normal adult serums, 69.1 per 
cent neutralized the virus of poliomyelitis.  Others ~6--9) have also demonstrated 
specific neutralizing substances for the virus of poliomyelitis  in the blood serum 
of non-convalescent  adults. 
Although the neutralizing power of these non-convalescent  serums has not been 
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compared with batches of convalescent serum, Shaughnessy, Harmon and Gordon 
(7) claim that the neutralizing power of serums from normal individuals may equal, 
or exceed, that of individual  convalescent  serum.  On the other hand,  Weyer, 
Park and Banzhaf (8) did not find any of six adult serums to equal the neutralizing 
power of either of two individual convalescent serums. 
Technique 
Cord virus which had been glycerinated  2 to 4 months was used.  In order to 
obtain a fairly even distribution  of virus, six or seven segments of each cord speci- 
men were used. 
The neutralization  test was carried  out as follows: 1 cc. of a  5 per cent cord 
emulsion and 1 cc. of serum were incubated 2 hours (with frequent  agitation)  and 
then, after a second period of 8 hours on ice, the mixture  was diluted  to 5 cc., 1 
cc. of which was injected into the frontal lobe of a monkey.  In the first test, 1 cc. 
of undiluted serum was added to 1 cc. of virus, but in the succeeding tests,  1 cc. of 
serum, diluted 1:2, 1:3, 1:4 and so forth, was added. 
EXPERIMENTAL 
The average level of neutralizing power of convalescent serum was 
determined by finding the smallest quantity of each of four batches of 
serum  which  would  neutralize  80  minimal  completly  paralyzing 
(•.c.P.)  doses of virus and then dividing the sum of these amounts by 
four.  For the purposes of this work, the ~.c.P. dose is limited to the 
smallest quantity of virus-containing tissue that will cause a  complete 
and  rapid  paralysis  in  monkeys weighing  2.5  to  4  kilos,  within  13 
days.  In my experience, less than a  completely paralyzing dose either 
failed to produce symptoms, or at most produced paralysis after a pro- 
longed incubation  period.  More  than  a  completely paralyzing dose 
invariably produced severe paralysis.  The constancy of these results 
leads me to believe that monkeys do not vary greatly in their individual 
susceptibility to the disease. 
Experiment/.--The separate  cords of three monkeys and a pool of cords from 
four monkeys, all removed at the height of paralysis  and preserved  in glycerine 2 
to  4  months,  were  titrated  in  order to determine  their  M.c.P. dose  (Table  I). 
Each gave approximately the same M.c.P. dose, which seems to indicate a remarka- 
ble constancy, for cord infected with this virus at least, at that stage of the disease. 
After a further period of 2½ months, the pooled specimen did not show any change 
in its infectivity. 
Experiment 2.--To determine  the average  neutralizing  power of convalescent 
serum,  the virus used  to test the convalescent  serums was a pooled specimen of MAURICE  BRODIE  509 
six segments from each of four separate cords and on the above evidence constant 
results were expected.  The virus emulsion, made up from cord tissue of each of 
these twenty-four segments, was titrated at the beginning and at the completion 
of the experiments and showed no appreciable change in its strength. 
Each batch of pooled convalescent serum represented that of twelve to twenty- 
eight donors, who had had the disease at least 2 years previously.  The results are 
given in Table II. 
TABLE  I 
Titration  of Four Specimens of Cord 
Monkey 
No. 
Pooled specimen 
(4)  Glycerlnated ~une and J'uly, 1931 
Titration ~ept. 1, 1931 
incubation perfod--5-7 days 
Result  Cord 
0.0625 
0.125 
0.250 
0,5 
1.0 
Monkey 
No. 
No paralysis 
Paralysis, 13 days 
~  9  ~ 
(I) Glycerinated  Mar. 15,  1931 
Titration Jul~ 15, 1931 
Incubation period--6 days 
Cord 
mg. 
0.03125 
0.0625 
0.125 
0.250 
Result 
No paralysis 
Paralysis, 23 days, slow 
course 
Paralysis,  10 days 
(2)  Glycerlnated 3rely 29, 1931 
Titration Sept.  18, 1931  (4) 2] mos. later 
Incubation period--13 days 
No paralysis 
Paralysis, 7 days 
0103125 
0.0625 
0.125 
(3) Glycerlnated  Aug. 7, 1931 
Titrated  Oct. 13, 1931 
Incubation period--7  days 
0.03125 
0.0625 
0.125 
No paralysis 
Paralysis, 7 days 
0.03125 
0.0625 
0.125 
No paralysis 
Paresis right arm 
Paralysis, 6 days 
Averaging the titrated neutralizing power of these four specimens of 
pooled  convalescent  serum,  representing  over a  hundred  donors,  a 
mean  of 0.04  cc.  neutralizing  80  M.c.P.  doses  of  virus  is  obtained. 
The batches of serum varied considerably in strength, for the weakest 
showed only 58 per cent of the neutralizing power of the strougest and 
the remaining two approximated to the arithmetical average figure. ~  o 
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Experiment 3.  The Titration  of Normal Adult Serums.--The adult serums were 
tested by the technique used in titrating convalescent serum.  A similar quantity 
of the same pooled virus was used and the tests were carried out at the same time, 
so  that,  when  neutralizing  substances  were  demonstrated,  the  titre  could be 
compared with  that  of  the  convalescent  serums.  Of  the  twenty-nine  adults 
tested, fourteen had a history of known contact with cases of poliomyelitis, but, 
in view of the recent work of Kramer and Aycock (10), as one was exposed but 2 
weeks prior to the tests, he was listed as a non-contact. 
In addition to titrating the virus at the beginning of the experiment and at the 
time of the last completed set of neutralization tests, an additional control monkey 
received a mixture of swine serum and virus, in order to show that the serum of an 
animal, said to be refractory to the virus of poliomyelitis (11), did not contain 
specific neutralizing substances.  The results are given in Table III. 
In the first test twenty-two or 76 per cent neutralized the virus, so 
that,  if  the  protective  power  is  expressed  in  terms  of  the  average 
protective  power  of  convalescent  serum,  seven  contained  less  than 
two-fifths the neutralizing power of the average for the four convales- 
cent  serums.  It is  possible  that  in  two  cases,  (Nos.  2  and  19),  the 
virus  was partially  neutralized  by the  serums,  for the  disease  ran  a 
much slower course than usual,  after incubation periods of 12 and  13 
days,  respectively. 
In the second test nineteen or 65 per cent neutralized, so that three 
were below three-fifths strength,  but  equal to two-fifths the strength 
of  convalescent  serum.  In  the  third  test,  two  failed  to  neutralize, 
and  so  contained  less  than  four-fifths  but  equalled  three-fifths  the 
strength  of convalescent  serum,  so that  seventeen had  at least four- 
fifths the protective power of the average for the four pooled convales- 
cent serums.  Of these seventeen, six out of the ten which were tested, 
equalled the neutralizing power of convalescent serum. 
The  pooled serum of non-contacts  had  at  least  two-fifths but less 
than  three-fifths  the  average  neutralizing  power  of  convalescent 
serum and the pooled serum of contacts had  at least three-fifths but 
less  than  four-fifths  the  average neutralizing  power  of  convalescent 
serum. 
Experiment 4.--The seven serums which  had not been worked out in Experi- 
ment  3,  which  had at  least  four-fifths the neutralizing power  of convalescent 
serum, were tested to determine whether or not they equalled the neutralizing 
power of convalescent serum.  In addition,  six of the normal serums which  at Z  Z" 
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TABLE  IV 
Blood 
donor  History of 
No.  contact 
10  None 
11  " 
12  " 
13  " 
14  " 
15  " 
23  6-8 wks. 
24  2  mos.  and 
previously 
25  2-3 mos. 
27  3  mos.  and 
previously 
28  Experimental 
disease 
29  "  " 
Convalescent Pool 5 
Test  4 
Cord 
.~mul- 
sion  Se-  Result  rum 
rag.  ¢¢. 
2.5  0.04  Paralysis,  5 days 
2.5  0.04  "  12  " 
2.5  0.04  No paralysis 
2.5  D.04  "  " 
Neutralized in last experiment 
2.5  0.04  Paralysis, 10 days 
2.5  0.04  "  6  " 
2.5  0.04  No paralysis 
Neutralized in last experiment 
2.5  [0.041  Neutralized 
Test 5 
Result 
Paralysis,  8 days 
"  11  " 
No paralysis 
Paralysis, 11 days 
"  15  " 
No paralysis 
Paralysis, 30 days 
Controls 
Mo~e, 
No. 
3-05 
3-04 
3-02 
Cord 
emulsion 
~g. 
0.0625 
0.125 
O. 250 
Result 
Paralysis, 6 days 
"  6  " 
~  7  ~ 
[onkey 
No. 
3 -08 
3-07 
2 -83 
2-62 
2-65 
Cord 
emulsion 
mg. 
0. 015625 
0.03125 
0.0625 
0.125 
0.125 
Result 
Paralysis, 23 days 
"  6  " 
"  6  " 
"  6  " 
t¢  5  ~¢ 
2.5 mg. of cord  =  80 M.C.P. doses. 
least equalled the average potency of the convalescent serums were selected and 
tested further.  As an additional comparison, a fifth sample of pooled convalescent 
serum was included in the experiment. 
The virus used in this experiment had four times the infectivity of that used in 
the  previous  experiment,  the  M.c.v.  dose  being 0.03125  mg.,  so  that  80  M.c.P. 
doses were represented in 2.5  rag.  of cord.  The results are shown in Table IV. 
Convalescent  serum,  Pool  5, containing  the serums  of twenty  donors, 
had  the  same  neutralizing  power  as  the  average  of  the  other  four 
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Of the  seven serums, which  showed in  the  last  test  at  least four- 
fifths the neutralizing power of convalescent serum, only three equalled 
the neutralizing power of convalescent serum.  Combining the results 
of Experiments 3  and 4, nine out of the twenty-nine serums tested at 
least equalled  the neutralizing power of convalescent serum.  Of the 
six of these  tested  further  (Test  5),  two  showed  higher  neutralizing 
power than the average of the convalescent serums. 
The results may be expressed as follows: 
Potencies of 7 serums were below 2/5 the average of the convalescent serums 
3  "  equalled  2/5  ............ 
2  ....  3/5  ............ 
8  ....  4/5  ...........  ' 
9  "  at least equalled"  ......  "  " 
Summary 
In 7 cases O. 1  ce. of serum failed to neutralize 80 ~.c.P. doses of virus 
"  3  "  0.07  ........  "  "  80  "  "  "  " 
"  2  "  0.05  "  "  ' .... '  "  80  "  "  .... 
"  8  "  0.04  "  "  "  "  "  "  80  ......  " 
"  9  "  0.04  "  "  "  neutralized  80  "  "  "  " 
Two out of six of these nine showed higher neutralizing power since 0.033 cc. of 
serum neutralized 80 ~.c.P. doses of virus and five pooled convalescent serums gave 
an average figure of 0.04 cc. of serum neutralizing 80 M.C.I'. doses of virus. 
DISCUSSION 
Of twenty-nine serums, the largest series of non-convalescent urban 
adults tested for antibody,  twenty-two or 76 per cent showed definite 
protective power against poliomyelitis  virus.  Two other serums ap- 
peared  to  give partial  neutralization,  since  in  the  animals  receiving 
these serums  the  disease ran a  much  slower  course  after  incubation 
periods of  12  and  13  days,  respectively; therefore,  in  this  series,  the 
incidence  of  specific  neutralizing  substances  against  the  virus  of 
poliomyelitis,  is  approximately  80  per  cent,  which  agrees  with  the 
figures obtained by Aycock and Kramer (4). 
Out of 16 non-contacts  tested,  12 had at least two-fifths,  10 had at 
least three-fifths, 8 had at least four-fifths and 4 had at least equal the 
average  of  the  neutralizing  power  of  the  convalescent  serums.  Of 
the  13 contacts tested,  10 had at least two-fifths, 9 had at least three- 
fifths, 9 had at least four-fifths and 5 had at least equal the neutralizing 
power of convalescent serum.  In this series then, known contacts and 516  CONVALESCENT  SER~  IN POLIO~[YELITIS 
avowed non-contacts were equally represented in  the serums of low 
potency, but  in  the  serums of higher potency the known  contacts 
predominated slightly.  The pool  of the  serums of known  contacts 
was of slightly higher value than the pool of the serums of non-con- 
tacts, but they were respectively a little above and a little below half 
the strength of the average obtained for pooled convalescent serum. 
Shaughnessy et  al.  (7),  comparing  individual convalescent and so 
called normal  adult  serums,  claimed that  the latter  had  as  a  rule 
better neutralizing power than the  former.  It is  quite likely, how- 
ever, that, in many of their neutralization tests, the virus tissue used 
was not active, since eight of fourteen controls did not contract paraly- 
sis with as much as 1 cc. of a  5 per cent emulsion (12).  This wide- 
spread distribution of neutralizing substances amongst adults and the 
high titre in more than half of them might result either from exposure 
to  the  virus  of poliomyelitis,  and  subsequent  immunity through  a 
subclinical attack of the disease, or it may occur as a natural matura- 
tion with age.  There is considerable epidemiological and experimental 
evidence to suppose that the former mechanism may be partly respon- 
sible for the development of the neutralizing substances in these adult 
serums.  Frost  (13), who first suggested this hypothesis, emphasized 
the differences in the age distribution of the disease in urban and rural 
districts and concluded that an immunity, which was directly propor- 
tional to concentration of population, developed with age.  In addi- 
tion, Aycock (14)  has shown that the age distribution  is similar  to 
that of measles and diphtheria and believes that subclinical infection 
accounts for the widespread immunity in adults against the virus of 
poliomyelitis.  As further evidence it has been shown that the inci- 
dence  of  neutralizing  substance  against  the  virus  of  poliomyelitis 
parallels the Schick test and that the incidence of this neutralizing 
substance increases with age according to concentration of population, 
(Aycock and Kramer (4)). 
The work here described confirms the high incidence of antibody 
amongst urban adults and shows that a  good proportion have a high 
degree  of  neutralizing  ability.  It  has  also  been  shown  that  the 
incidence of more potent serum is greater amongst contacts, the ma- 
jority of whom had frequent exposure to  the virus,  than  amongst 
non-contacts, which supports the hypothesis that exposure is a factor 
in bringing about immunity. M.AURICE  BRODIE  517 
The Clinical Use of This Serum 
To meet an emergency, serum was collected, for  therepeutic pur- 
poses,  from  eleven  of  the  seventeen normal persons  showing  high 
protective power in  their serum, on  the grounds that  these serums 
seemed to be quite as strong as the average convalescent serum, and 
that larger quantities could be obtained from adults than from con- 
valescent patients, the majority of whom are children. 
Over 8 litres of blood was collected and the pooled serum was used 
in the treatment of sixteen early cases which occurred at the height of 
the epidemic.  In Table V  a  comparison is made between these and 
twenty-five cases,  which occurred at  approximately the same  time 
and which were treated with convalescent serum. 
TABLE  V 
Serum 
Convalescent 
Selected  adult 
No.  Total 
CS,  Se ;  Sei't11]] 
CO. 
25  21-25 
4--50 
16  7-25 
9-50 
No paralysis 
No.  Per cent 
20  80 
13  81.2 
Mild paralysis 
No.  Per centl 
2  8 
0  0 
Severeparalysis  Deaths 
No.  Per cen!  No.  Percen! 
3  12  1  4 
3  18.8  1  6.3 
The series is small and difficult to interpret, but the rapid fall of 
temperature and the amelioration of sYmptoms  ,  in  the cases which 
did not develop paralysis, was equally evident with the serum from 
both  sources. 
Three  cases which developed paralysis following non-convalescent 
serum and five which contracted paralysis after the administration of 
convalescent serum, did not show any fall of pulse or temperature or 
any symptomatic improvement after the intravenous administration 
of serum. 
In these early cases of poliomyelitis, there is a similarity in the re- 
sponses  to  convalescent  and  high  titre  non-convalescent  serums. 
Zingher  (15)  reported satisfactory results,  for a  small  series of pre- 
paralytic  poliomyelitis  patients,  with  large  quantities  of  pooled 
untested serum from normal adults. 
The supply of convalescent serum, children being the usual source, 518  CONVALESCENT  SERUM  IN POLIOMYELITIS 
will not always meet demands in an epidemic.  The present  observa- 
tions  indicate  that  the  supply  can  be  considerably  augmented  by 
serum of tested adults.  Furthermore, by obtaining serum from tested 
adults, the donor list is reduced and there is a considerable amount of 
time saved.  In order to obtain  13.5 litres of convalescent serum for 
the  1931  epidemic in  Montreal,  200 bleedings were necessary and  a 
donor list of 150 persons was used. 
CONCLUSIONS 
1.  Of twenty-nine so called normal urban adults tested, seven had 
less than  two-fifths, three had  two-fifths, two had  three-fifths,  eight 
had  four-fifths and  nine  had  a  neutralizing  power at  least  equal  to 
the average of five batches of pooled convalescent serum. 
2.  Known  contacts  and  avowed non-contacts  were equally repre- 
sented  in  the  serums  of  low  potency,  but  in  the  serums  of  higher 
potency, the known contacts predominated. 
3.  The pooled serums  of known contacts and of non-contacts were 
respectively a  little above and a  little below half the strength of the 
average obtained for  pooled convalescent serum. 
4.  Two series of early cases  of poliomyelitis,  the one treated with 
normal serum of proved protective power, the other with convalescent 
serum, showed no advantage of one type of serum over the other. 
I  wish to thank  Professor E. G. D. Murray for his advice and sug- 
gestions throughout the course of this work, and the Staff of the Chil- 
dren's Memorial Hospital for their kindness in making  these clinical 
studies possible. 
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